Semaglutide is a medication that belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. It is used as a treatment for obesity and works by reducing appetite and promoting weight loss.
Semaglutide is a synthetic version of a naturally occurring hormone called GLP-1 that is produced in the intestines. GLP-1 is released in response to food intake and acts on receptors in the brain, pancreas, and other organs to regulate glucose metabolism, appetite, and satiety. Semaglutide mimics the actions of GLP-1 and activates GLP-1 receptors in the brain, which can help reduce appetite and increase feelings of fullness or satiety.
The exact mechanism by which Semaglutide promotes weight loss is not entirely understood, but it is believed to involve multiple factors. Semaglutide is thought to slow down gastric emptying, which can lead to reduced food intake and increased satiety. It is also believed to decrease hunger signals in the brain, leading to reduced appetite. Additionally, Semaglutide may increase energy expenditure and promote weight loss by increasing the body’s sensitivity to insulin and reducing the amount of glucose produced by the liver.